These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1582303)

  • 1. Efficacy of a low dose of cefotaxime in serious chest infections.
    Cade JF; Presneill J; Keighley C; Sinickas V
    Chest; 1992 May; 101(5):1393-8. PubMed ID: 1582303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of effectiveness of cefodizime in the treatment of lower respiratory tract infections with parenchymal involvement.
    Pauwels RA
    Infection; 1992; 20 Suppl 1():S26-30. PubMed ID: 1526672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The optimal dosage of ceftazidime for severe lower respiratory tract infections.
    Cade JF; Presneill J; Sinickas V; Hellyar A
    J Antimicrob Chemother; 1993 Oct; 32(4):611-22. PubMed ID: 8288503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic prophylaxis of respiratory tract infection in mechanically ventilated patients. A prospective, blinded, randomized trial of the effect of a novel regimen.
    Aerdts SJ; van Dalen R; Clasener HA; Festen J; van Lier HJ; Vollaard EJ
    Chest; 1991 Sep; 100(3):783-91. PubMed ID: 1889273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of ceftriaxone with cefotaxime in serious chest infections.
    Reeves JH; Russell GM; Cade JF; McDonald M
    Chest; 1989 Dec; 96(6):1292-7. PubMed ID: 2684552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and pharmacological evaluation of a modified cefotaxime bid regimen versus traditional tid in pediatric lower respiratory tract infections.
    Boccazzi A; Tonelli P; Bellosta C; Careddu P
    Diagn Microbiol Infect Dis; 1998 Dec; 32(4):265-72. PubMed ID: 9934543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once-daily therapy with ceftriaxone compared with daily multiple-dose therapy with cefotaxime for serious bacterial infections: a randomized, double-blind study.
    Mandell LA; Bergeron MG; Ronald AR; Vega C; Harding G; Saginur R; Feld R; Duperval R; Landis SJ; Miedzinski LJ
    J Infect Dis; 1989 Sep; 160(3):433-41. PubMed ID: 2668427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftriaxone compared with cefotaxime for serious bacterial infections.
    Smith CR; Petty BG; Hendrix CW; Kernan WN; Garver PL; Fox K; Beamer A; Carbone K; Threlkeld M; Lietman PS
    J Infect Dis; 1989 Sep; 160(3):442-7. PubMed ID: 2668428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous vs. intermittent cefotaxime administration in patients with chronic obstructive pulmonary disease and respiratory tract infections: pharmacokinetics/pharmacodynamics, bacterial susceptibility and clinical efficacy.
    van Zanten AR; Oudijk M; Nohlmans-Paulssen MK; van der Meer YG; Girbes AR; Polderman KH
    Br J Clin Pharmacol; 2007 Jan; 63(1):100-9. PubMed ID: 16869814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative evaluation of oral ofloxacin versus intravenous cefotaxime therapy for serious skin and skin structure infections.
    Gentry LO; Rodriguez-Gomez G; Zeluff BJ; Khoshdel A; Price M
    Am J Med; 1989 Dec; 87(6C):57S-60S. PubMed ID: 2690621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of clarithromycin compared to cefixime as outpatient treatment of lower respiratory tract infections.
    Neu HC; Chick TW
    Chest; 1993 Nov; 104(5):1393-9. PubMed ID: 8222794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefotaxime therapy of lower respiratory tract infections in intensive-care patients.
    Rondanelli R; Dionigi RV; Calvi M; Dell'Antonio M; Corsico G; Mapelli A
    Int J Clin Pharmacol Res; 1987; 7(1):73-6. PubMed ID: 3583490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of cefotaxime single administration and of cefotaxime + fosfomycin administration against respiratory tract infections].
    Shimokata K; Torigai K; Kato M; Sakai S; Nomura F; Ito T; Saka H; Senda Y; Torii Y; Ito T
    Jpn J Antibiot; 1988 Sep; 41(9):1261-71. PubMed ID: 3071617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic prophylaxis in elective genitourinary tract surgery: a comparison of single-dose pre-operative cefotaxime and multiple-dose cefoxitin.
    Childs SJ; deBessonet DA; Merlin AS
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():271-5. PubMed ID: 6094451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of lower respiratory tract infections including pneumonia. Comparative study with i.vl cefotaxime/oral cefixime versus parenteral cefotaxime].
    Vogel F
    Fortschr Med; 1994 Oct; 112(28):395-8. PubMed ID: 7988978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefodizime given in single or divided doses for the treatment of lower respiratory tract infection.
    Palombini BC; André-Alves MR; Dagrosa EE
    Arzneimittelforschung; 1997 Mar; 47(3):299-302. PubMed ID: 9105549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of ceftizoxime administered twice daily in hospitalized patients with respiratory tract infections.
    Lentnek A; Wikler M; McDevitt J; Sohn C
    Clin Ther; 1984; 7(1):33-9. PubMed ID: 6097357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative clinical evaluation of ceftriaxone in treating lower respiratory tract infections.
    Abbate GF; Alagia I; Giaquinto E; Leonessa V; Caputi M; Guarino C; Micillo E; Catena E; Altucci P
    Chemioterapia; 1986 Feb; 5(1):26-32. PubMed ID: 3955779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ampicillin/sulbactam compared with cefotaxime in the treatment of lower respiratory tract infections of bacterial etiology.
    Jauregui L; Minns P; Hageage G
    Adv Ther; 1995; 12(1):62-71. PubMed ID: 10150322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-dose ceftriaxone versus multi-dose cefotaxime as short-term antimicrobial prophylaxis in urologic surgery. Preliminary results of a multicenter prospective randomized study.
    Periti P; Mazzei T; Lamanna S; Mini E
    Chemioterapia; 1984 Oct; 3(5):295-8. PubMed ID: 6099756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.